Afect of botulinum toxin-A injection on intraocular pressure and proptosis in thyroid associated orbitopathy

Coll Antropol. 2009 Dec;33(4):1155-7.

Abstract

The aim of this study was to evaluate the effects of extraocular muscle injection of botulinum toxin-A (BTX-A) on intraocular pressure (IOP) and proptosis in patients with ocular motility disturbances in thyroid associated orbitopathy (TAO). In 17 patients (20 eyes) with restrictive strabismus and diplopia, BTX-A injections were applied. Intraocular pressure was measured with a Goldmann applanation tonometer in primary gaze position before and 2-4 weeks after BTX-A injection. Extraorbital prominention of the eyeball was measured before and after BTX-A injection using a Hertel instrument. Before the injection, the mean IOP in primary position of gaze was 18.6 +/- 2.8 mmHg and 2-4 weeks after BTX-A injection was 16.9 +/- 3.3 mmH; (p = 0.001). There was no statistically significant difference in Hertel egzophthalmometer readings before and after BTX-A injection, 21.5 +/- 2.7 mm vs. 22.0 +/- 2.6 mm; (p = 0.678). In conclusion, BTX-A injection has a secondary lowering effect on IOP in TAO due to relaxation of extraocular muscles, but with no influence on proptosis.

MeSH terms

  • Adult
  • Botulinum Toxins, Type A / pharmacology*
  • Botulinum Toxins, Type A / therapeutic use
  • Exophthalmos / drug therapy
  • Female
  • Graves Ophthalmopathy / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Neuromuscular Agents / pharmacology*
  • Neuromuscular Agents / therapeutic use
  • Ocular Hypertension / drug therapy
  • Retrospective Studies

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A